A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19
Clinical trial NCT04397562 · COMPLETED
Trial details
- NCT number
- NCT04397562
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2020-07-03
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.